| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002940 | 昂利康 | 62.92 | 10.00% | 11.62万 | 7.17亿 | | 601089 | 福元医药 | 26.54 | 9.99% | 10.13万 | 2.68 亿 | | 600774 | 汉商集团 | 12.46 | 9.97% | 31.00万 | 3.72亿 | | 002370 | 亚太药业 | 7.40 | 9.96% | 309.35万 | 22.01亿 | | 002437 | 营衡药业 | 4.04 | 8.89% | 482.38万 | 19.13 Z | | 300966 | 并同药业 | 26.68 | 8.41% | 29.78万 | 8.08亿 | | 688658 | 倪康药业 | 33.79 | 7.82% | 16.60万 | 5.72亿 | | 688091 | 上海谊众 | 77.63 | 7.79% | 12.47万 | 9.36 Z | | 600513 | 联环药业 | 4 ...

格隆汇8月1日｜医药板块持续大涨，众生药业、联环药业、汉商集团等近10只个股涨停，悦康药业涨逾 12%，维康药业涨逾9%。 ...

Group 1 - The assisted reproductive industry is experiencing a strong upward trend, with companies such as HanShang Group, FuYuan Pharmaceutical, and LiDeMan reaching their daily price limit [1] - Other companies in the sector, including GongTong Pharmaceutical, DaJia WeiKang, SiChuang YiHui, BoTuo Bio, BeiRui Gene, and MaiDi Technology, also saw significant increases in their stock prices [1]

Group 1 - The pharmaceutical sector experienced a significant surge on August 1, with multiple stocks hitting the daily limit up, including Zhongsheng Pharmaceutical, Lianhuan Pharmaceutical, and Hanchang Group [1] - Yuekang Pharmaceutical saw an increase of over 12%, while Weikang Pharmaceutical rose by more than 9% [1]

Group 1 - The pharmaceutical sector is experiencing a significant surge, with multiple stocks reaching their daily limit up [1] - Notable performers include Zhongsheng Pharmaceutical, Lianhuan Pharmaceutical, and Hanshang Group, among nearly 10 stocks hitting the limit up [1] - Yuekang Pharmaceutical has increased by over 12%, while Weikang Pharmaceutical has risen by over 9% [1]

Group 1 - The innovative drug sector is experiencing a significant rise, with companies such as Shutaishen (300204), Rejing Bio, Kangchen Pharmaceutical (603590), Fuyuan Pharmaceutical (601089), and Yuekang Pharmaceutical reaching historical highs during trading [1] - Qizheng Tibetan Medicine (002287) has achieved three consecutive trading limit increases, while Hanshang Group (600774) has seen two consecutive limit increases [1] - Other companies including Lianhuan Pharmaceutical (600513), Guizhou Bailing (002424), Anglikang (002940), Xintian Pharmaceutical (002873), and Zhongsheng Pharmaceutical (002317) have also hit trading limits, with Weikang Pharmaceutical (300878) and Dajia Weikang (301126) rising over 10% [1]

辅助生殖概念持续走强，汉商集团、福元医药、利德曼涨停，共同药业、达嘉维康、思创医惠、博拓生 物、贝瑞基因、麦迪科技等跟涨。 ...

Market Performance - On the last trading day of July, all three major A-share indices fell by over 1%, with the Shanghai Composite Index closing below 3600 points at 3573.21, down 1.18% [1] - The Shenzhen Component Index dropped 1.73% to 11009.77, while the ChiNext Index decreased by 1.66% to 2328.31 [1] - The total trading volume in the Shanghai and Shenzhen markets reached 1.96 trillion yuan [1] Sector Performance - The sectors that saw gains included liquid cooling IDC, assisted reproduction, Google, biopharmaceuticals, chemical pharmaceuticals, and computers [1] - Conversely, sectors that experienced declines included aquaculture, PTA, iron ore, energy metals, steel, and minor metals [1] Notable Stocks - The AI sector showed strong fluctuations, with Yidian Tianxia (301171) hitting the 20% daily limit up [1] - The liquid cooling server sector performed well, with Sihua New Materials (301489) also reaching the 20% limit up, alongside Yingweike (002837) and Chunz中科技 (603516) [1] - The assisted reproduction sector continued to strengthen, with Gongtong Pharmaceutical (300966) and Anke Biotechnology (300009) both hitting the 20% limit up, while Hanshang Group (600774) also reached the limit [1] - The steel sector faced adjustments, with Baogang Co. (600010) dropping over 8% [1] - The coal sector declined across the board, with Antai Group (600408) falling over 7% [1] Market Outlook - According to Jifeng Investment Advisory, the A-share market is expected to continue a structural trend in August, supported by the intensive disclosure of mid-term performance and ongoing policy efforts, favoring industries with high earnings certainty [1] - Dongfang Securities noted that the current A-share market is in a sustained upward trend with ample trading volume, attracting new capital, and maintaining a cautiously optimistic sentiment without immediate risk of reversal [2]

Core Viewpoint - The assisted reproduction sector has shown a positive performance with a 1.72% increase, ranking third among concept sectors, driven by significant gains in several stocks [1][2]. Group 1: Sector Performance - As of July 31, the assisted reproduction concept increased by 1.72%, with 34 stocks rising, including Anke Bio and Gongtong Pharmaceutical, which both hit the 20% limit up [1]. - Notable gainers in the sector included Guangshengtang, Xinghao Pharmaceutical, and Hanyu Pharmaceutical, with increases of 18.04%, 8.03%, and 7.02% respectively [1]. - Conversely, stocks such as Jiabiyou, Changchun High-tech, and Zhejiang Medicine experienced declines of 3.70%, 3.02%, and 2.99% respectively [1]. Group 2: Capital Flow - The assisted reproduction sector saw a net inflow of 0.18 billion yuan, with 30 stocks receiving net inflows from major funds [2]. - Anke Bio led the sector with a net inflow of 4.09 billion yuan, followed by Zhongsheng Pharmaceutical and Hanshang Group with net inflows of 2.04 billion yuan and 1.44 billion yuan respectively [2]. - The top three stocks by net inflow ratio were Hanshang Group at 53.93%, Lideman at 35.62%, and Gongtong Pharmaceutical at 23.90% [3].

截至收盘，上证指数报收3573.21点，下跌1.18%；深证成指收于11009.77点，下跌1.73%；创业板指下 跌1.66%；科创50指数下跌1.01%。 | 002940 | 昂利康 | 57.20 | 11.32 | 67.85 | 3880.99 | 医药生物 | | --- | --- | --- | --- | --- | --- | --- | | 600828 | 茂业商业 | 4.66 | 5.07 | 813.93 | 3792.90 | 商贸零售 | | 600774 | 汉商集团 | 11.33 | 8.01 | 322.68 | 3655.95 | 医药生物 | | 002799 | 环球印务 | 9.24 | 9.38 | 352.96 | 3261.36 | 轻工制造 | | 603516 | 淳中科技 | 60.48 | 11.90 | 52.57 | 3179.43 | 计算机 | | 001318 | 阳光乳业 | 18.14 | 18.45 | 158.69 | 2878.64 | 食品饮料 | | 603273 | 天元智能 | 21.09 | 38.88 | 122 ...